MAgnetic Resonance Imaging-guided implanTation of Cardioverter DEFibrillators

NANot yet recruitingINTERVENTIONAL
Enrollment

1,812

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

April 1, 2030

Study Completion Date

April 1, 2030

Conditions
Myocardial InfarctionVentricular TachycardiaVentricular FibrillationSudden Cardiac Death
Interventions
DEVICE

MRI screening

Cardiac Magnetic Resonance imaging for the quantification of the infarct intramural scar

DEVICE

Implantable Loop Recorder

Inplantation of the Implantable Loop Recorder (ILR) for the patients assigned to the experimental group

DEVICE

Implantable Cardioverter Defibrillator

Inplantation of the Implantable Cardioverter Defibrillator (ICD) for the patients assigned to the control group, according to the current guidelines

Trial Locations (1)

54511

CHRU Nancy, Vandœuvre-lès-Nancy

All Listed Sponsors
lead

Central Hospital, Nancy, France

OTHER

NCT06269692 - MAgnetic Resonance Imaging-guided implanTation of Cardioverter DEFibrillators | Biotech Hunter | Biotech Hunter